Trial Profile
Very long-term effects of the "4 PLUS 2 Infusion Protocol" of rituximab alone in patients with HCV-associated mixed cryoglobulinaemia with diffuse membranoproliferative glomerulonephritis, severe polyneuropathy and necrotic skin ulcers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Cryoglobulinaemia
- Focus Therapeutic Use
- 09 Dec 2015 New trial record